A Phase I Clinical Trial To Assess The Safety, Pharmacokinetics, And Antitumor Activity Of Glumetinib (Scc244) In Patients With Advanced Non-Small Cell Lung Cancers (Nsclcs).
JOURNAL OF CLINICAL ONCOLOGY（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要